Neha Sharmaa,
Swetlana Gautama,
Uma Devib,
Manjari Singha,
Jitendra K. Rawata,
Nikunj Sethic,
Shubhini A. Sarafa and
Gaurav Kaithwas*a
aDepartment of Pharmaceutical Sciences, School of Biosciences and Biotechnology, Babasaheb Bhimrao Ambedkar University, Vidya Vihar, Raebareli Road, Lucknow 226 025, U.P., India. E-mail: gauravpharm@hotmail.com; Tel: +91-9670204349
bDepartment of Pharmaceutical Sciences, Faculty of Health Medical Sciences Indigenous and Alternative Medicine, SHIATS-Deemed to be University Formerly Allahabad Agricultural Institute, Naini, Allahabad, U.P., India
cInstitute of Pharmacy, Chatrapati Sahuji Maharaj University, Kanpur-208024, India
First published on 11th December 2015
Correction for ‘Preclinical appraisal of terbutaline analogues in precipitation of autism spectrum disorder’ by Neha Sharma et al., RSC Adv., 2015, 5, 39003–39011.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2015 |